Cargando…

Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran

Background: Triple-negative breast cancers (TNBC) have a more aggressive course and are associated with poorer prognosis in comparison with other subtypes of breast cancer. One of the most common subtypes of TNBC is basal-like. The aim of this study was to investigate clinicopathological characteris...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirzania, Mehrzad, Safaee, Seyed Reza, Shahi, Farhad, Jahanzad, Issa, Zahedi, Ghazal, Mehdizadeh, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338280/
https://www.ncbi.nlm.nih.gov/pubmed/28286613
_version_ 1782512522310451200
author Mirzania, Mehrzad
Safaee, Seyed Reza
Shahi, Farhad
Jahanzad, Issa
Zahedi, Ghazal
Mehdizadeh, Reza
author_facet Mirzania, Mehrzad
Safaee, Seyed Reza
Shahi, Farhad
Jahanzad, Issa
Zahedi, Ghazal
Mehdizadeh, Reza
author_sort Mirzania, Mehrzad
collection PubMed
description Background: Triple-negative breast cancers (TNBC) have a more aggressive course and are associated with poorer prognosis in comparison with other subtypes of breast cancer. One of the most common subtypes of TNBC is basal-like. The aim of this study was to investigate clinicopathological characteristics and clinical course of TNBC in Iranian women and compare them with other studies. Subjects and Methods: Between March 2009 and February 2011, patients with breast cancer in Cancer Institute of Iran were selected and then followed-up for 2 years. Paraffin-embedded tumor block of all TNBC patients were evaluated for CK5/6 and EGFR using IHC method. Results: Among 267 breast cancer patients, 60 cases with TNBC were identified (22.5%), 31 patients (51.7%) had basal-like and 29 patients (48.3%) had non-basal-like tumors. The median age of participants with TNBC was 49.6 years. Among our patients, 70% had positive lymph nodes.93.4% of all patients at the time of diagnosis were stage II or III and tumor size was at least 3 centimeters. No grade 1 TNBC was found in this study. During the follow-up period, there were 26 recurrences and 7 deaths. Conclusion: The percentage of basal-like subtype among Iranian women with TNBC was lower compared to other studies, while bone metastases, clinical stage, lymph node involvement and tumor size were higher. Clinicopathological findings in basal and non-basal-like subgroups were not different, but the probability of lymph node involvement was more common in patients who were EGFR positive.
format Online
Article
Text
id pubmed-5338280
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
record_format MEDLINE/PubMed
spelling pubmed-53382802017-03-10 Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran Mirzania, Mehrzad Safaee, Seyed Reza Shahi, Farhad Jahanzad, Issa Zahedi, Ghazal Mehdizadeh, Reza Int J Hematol Oncol Stem Cell Res Original Article Background: Triple-negative breast cancers (TNBC) have a more aggressive course and are associated with poorer prognosis in comparison with other subtypes of breast cancer. One of the most common subtypes of TNBC is basal-like. The aim of this study was to investigate clinicopathological characteristics and clinical course of TNBC in Iranian women and compare them with other studies. Subjects and Methods: Between March 2009 and February 2011, patients with breast cancer in Cancer Institute of Iran were selected and then followed-up for 2 years. Paraffin-embedded tumor block of all TNBC patients were evaluated for CK5/6 and EGFR using IHC method. Results: Among 267 breast cancer patients, 60 cases with TNBC were identified (22.5%), 31 patients (51.7%) had basal-like and 29 patients (48.3%) had non-basal-like tumors. The median age of participants with TNBC was 49.6 years. Among our patients, 70% had positive lymph nodes.93.4% of all patients at the time of diagnosis were stage II or III and tumor size was at least 3 centimeters. No grade 1 TNBC was found in this study. During the follow-up period, there were 26 recurrences and 7 deaths. Conclusion: The percentage of basal-like subtype among Iranian women with TNBC was lower compared to other studies, while bone metastases, clinical stage, lymph node involvement and tumor size were higher. Clinicopathological findings in basal and non-basal-like subgroups were not different, but the probability of lymph node involvement was more common in patients who were EGFR positive. Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center 2017-01-01 /pmc/articles/PMC5338280/ /pubmed/28286613 Text en Copyright : © International Journal of Hematology-Oncology and Stem Cell Research & Tehran University of Medical Sciences This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Mirzania, Mehrzad
Safaee, Seyed Reza
Shahi, Farhad
Jahanzad, Issa
Zahedi, Ghazal
Mehdizadeh, Reza
Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title_full Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title_fullStr Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title_full_unstemmed Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title_short Treatment Outcomes and Clinicopathologic Characteristics of Triple-Negative Breast Cancer: A Report from Cancer Institute of Iran
title_sort treatment outcomes and clinicopathologic characteristics of triple-negative breast cancer: a report from cancer institute of iran
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5338280/
https://www.ncbi.nlm.nih.gov/pubmed/28286613
work_keys_str_mv AT mirzaniamehrzad treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran
AT safaeeseyedreza treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran
AT shahifarhad treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran
AT jahanzadissa treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran
AT zahedighazal treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran
AT mehdizadehreza treatmentoutcomesandclinicopathologiccharacteristicsoftriplenegativebreastcancerareportfromcancerinstituteofiran